Fidelity Investments
BCAB icon

Fidelity Investments’s BioAtla BCAB Stock Holding History

Fidelity Investments’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-957
Closed -$28.3K – 5304
2024
Q4 		$28.3K Sell
957
-33
-3% -$2.77K ﹤0.01% 4090
2024
Q3 		$87.1K Sell
990
-43
-4% -$3.61K ﹤0.01% 3537
2024
Q2 		$70.8K Buy
1,033
+966
+1,442% +$115K ﹤0.01% 3447
2024
Q1 		$11.6K Buy
67
+5
+8% +$621 ﹤0.01% 4220
2023
Q4 		$7.59K Buy
62
+5
+9% +$433 ﹤0.01% 4321
2023
Q3 		$4.84K Buy
57
+20
+54% +$2.55K ﹤0.01% 4336
2023
Q2 		$5.61K Sell
37
-42
-53% -$7.22K ﹤0.01% 4331
2023
Q1 		$10.6K Buy
79
+52
+193% +$9.37K ﹤0.01% 4104
2022
Q4 		$11.3K Sell
27
-353
-93% -$146K ﹤0.01% 3969
2022
Q3 		$146K Sell
380
-5,917
-94% -$1.94M ﹤0.01% 3147
2022
Q2 		$897K Sell
6,297
-52,092
-89% -$8.29M ﹤0.01% 2702
2022
Q1 		$14.6M Sell
58,389
-20,024
-26% -$8.38M ﹤0.01% 1944
2021
Q4 		$77M Sell
78,413
-17,675
-18% -$22.6M 0.01% 1229
2021
Q3 		$141M Buy
96,088
+1,149
+1% +$2.24M 0.01% 958
2021
Q2 		$201M Buy
94,939
+13,387
+16% +$30.2M 0.02% 829
2021
Q1 		$207M Buy
81,552
+45,950
+129% +$118M 0.02% 774
2020
Q4 		$60.5M Buy
+35,602
New +$59.5M 0.01% 1246

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Fidelity Investments's BCAB Position: Q1 2025 in Review

Fidelity Investments sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 957 shares — an estimated $28.3K sold.

Fidelity Investments first reported a position in BCAB in Q4 2020 and held it in 17 quarters. The position peaked at $207M in Q1 2021. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

  • Fidelity Investments reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 957 BioAtla shares in Q1 2025, an estimated $28.3K.
  • Fidelity Investments first reported a position in BioAtla in Q4 2020 and held it in 17 quarters.
  • Fidelity Investments's BioAtla position peaked at $207M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.